首页> 外文期刊>Neuro-Oncology >The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, lp/19q-intact lower-grade glioma: a validation study
【24h】

The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, lp/19q-intact lower-grade glioma: a validation study

机译:T2-FLAIR不匹配体征作为非增强型IDH突变型lp / 19q完整低级神经胶质瘤的成像标记:一项验证研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background. The purpose of this study was to assess the reproducibility of the previously described T2-fluid attenuated inversion recovery (FLAIR) mismatch sign as a specific imaging marker in non-enhancing isocitrate dehydrogenase (IDH) mutant, 1p/19q non-codeleted lower-grade glioma (LGG), encompassing both diffuse and anaplastic astrocytoma.
机译:背景。这项研究的目的是评估先前描述的T2流体减毒反转恢复(FLAIR)错配符号作为非增强型异柠檬酸脱氢酶(IDH)突变体1p / 19q非编码低级突变中的特定成像标记的重现性胶质瘤(LGG),包括弥漫性和间变性星形细胞瘤。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号